Ligand validation:4IMF

ME2: 1-ETHOXY-2-(2-METHOXYETHOXY)ETHANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IMF_ME2_B_302	73%	68%	0.106	0.933	0.5	0.74	-	-	0	0	100%	1
4IMF_ME2_B_303	42%	61%	0.159	0.879	0.87	0.63	-	-	4	0	100%	1
4IMF_ME2_A_302	41%	64%	0.176	0.891	0.75	0.65	-	-	2	0	100%	1
4IME_ME2_G_301	52%	79%	0.123	0.881	0.44	0.43	-	-	6	0	100%	1
2Y2V_ME2_A_1545	54%	53%	0.176	0.943	0.52	1.26	-	-	2	0	100%	1
4FRU_ME2_A_203	46%	51%	0.127	0.861	0.64	1.24	-	1	0	0	100%	1
5VFN_ME2_B_201	18%	66%	0.215	0.839	0.7	0.6	-	-	1	0	80%	0.8
3O4P_ME2_A_471	18%	47%	0.239	0.826	0.96	1.07	-	1	7	0	100%	0.67
1PJX_ME2_A_471	11%	47%	0.228	0.741	0.95	1.09	-	1	9	0	100%	0.67

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.